Guillain Barré syndrome, a possible side effect of buffy coat transfusion and IFN alpha therapy in relapsed CML after bone marrow transplantation.

Autor(es): Schwarzer A.; Schulze E.; Leiblein S.; Krahl R.; Kubel M.; Bartram C.; Edelmann J.; Sack U.; Helbig W.


Imprenta: Annals of Oncology, v. 6, n. 6, p. 617, 1995


Identificador do objeto digital: 10.1093/oxfordjournals.annonc.a059254


Descritores: Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Cytokines


Data de publicação: 1995